NCAM1 and nasopharyngeal carcinoma: While we detected higher levels of markers associated with effector responses, such as CD20, GZMB, and CD56 in ‘immune-rich cancer cell islet’ regions, additional expression of markers such as PD-1 and FOXP3 in the same regions may reflect mechanisms associated with tumor growth in NPC.